Leukemia
General Information
A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd TÂ Lymphoblastic Lymphoma (T-LLy)
Pediatrics
AALL1231
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
Eligibility Information
Ineligibility Information